As of 4:00pm ET
| -0.02 / -0.45%|
The 3 analysts offering 12-month price forecasts for Aratana Therapeutics Inc have a median target of 8.00, with a high estimate of 10.00 and a low estimate of 5.00. The median estimate represents a +81.82% increase from the last price of 4.40.
The current consensus among 4 polled investment analysts is to Buy stock in Aratana Therapeutics Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.